Literature DB >> 35692300

Novel Single Nucleotide Polymorphisms (SNPs) and Genetic Features of the Prion Protein Gene (PRNP) in Quail (Coturnix japonica).

Yoonhee Kim1,2, Yong-Chan Kim1,2, Byung-Hoon Jeong1,2.   

Abstract

Prion diseases are fatal infectious diseases caused by conformational changes of a prion protein (PrPSc) derived from a normal prion protein (PrPC). Prion diseases have been reported in several mammalian hosts but not in any birds, including the most popular poultry species, of which chickens showed some resistance to experimental prion infection. To identify the genetic polymorphisms in the quail prion protein gene (PRNP), polymerase chain reaction and DNA sequencing were performed with gene-specific primers in 164 quails. Four in silico programs, including PROVEAN, PANTHER, SIFT, and AMYCO, were used to investigate the effect of non-synonymous single nucleotide polymorphisms (SNPs) on quail PrP. Furthermore, to investigate the genetic relationship of avian PrPs, phylogenetic analysis and multiple sequence alignments were performed using MEGA X program. Finally, the secondary and tertiary structures of avian PrPs were analyzed by SWISS-MODEL. We identified 33 novel SNPs in the quail PRNP gene, including three non-synonymous SNPs, c.56C>T (T19I), c.60C>T (V21I), and c.61G>A (A22S). Although V21I was predicted to have deleterious effects by SIFT, the substitutions of all three amino acids did not affect the amyloid propensity, 3D structure, or hydrogen bonds of quail PrP. Quail PrP showed a close evolutionary relationship and similar secondary and tertiary structures to chicken PrP compared to duck PrP. To our knowledge, this is the first report on the genetic and structural properties of the quail PRNP gene.
Copyright © 2022 Kim, Kim and Jeong.

Entities:  

Keywords:  PRNP; SNP; polymorphism; prion; quail; quail (Coturnix japonica)

Year:  2022        PMID: 35692300      PMCID: PMC9174905          DOI: 10.3389/fvets.2022.870735

Source DB:  PubMed          Journal:  Front Vet Sci        ISSN: 2297-1769


Introduction

Prion diseases are fatal infectious neurodegenerative diseases characterized by spongiform vacuolation and activated glial cells (1). To date, there is no suitable treatment or vaccine to prevent prion diseases. Prion diseases are caused by the β-sheet rich and aggregated form of the prion protein (PrPSc), which originates from the endogenous benign form of the prion protein (PrPC) (2). Prion diseases show wide host ranges in several mammals, including Creutzfeldt–Jakob disease (CJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and fatal familial insomnia (FFI) in humans, bovine spongiform encephalopathy (BSE) in cattle, chronic wasting disease (CWD) in elks and deer, scrapie in sheep and goats, and camel prion disease (CPD) in camels (3–6). Previous studies have reported that genetic polymorphisms affecting the structure and expression level of PrP are significantly related to susceptibility to prion diseases (7, 8). In humans, non-synonymous single nucleotide polymorphisms (SNPs) at codons 129 and 219 of the prion protein gene (PRNP) were associated with susceptibility to CJD (9–11). In addition, the 23 and 12 bp insertion/deletion polymorphisms located in the promoter region were associated with the expression of the bovine PRNP gene and were reported to affect vulnerability to BSE (12). Furthermore, genetic polymorphisms at codons 95, 96, and 132 of the cervid PRNP gene played an important role in susceptibility to CWD in the cervidae family (13–15). Recent studies have reported that prion disease-resistant specific amino acids of PrPs, including S167 in horses and D159 in dogs, conferred resistance to conversion from PrPC to PrPSc (16, 17). In chicken PrP, although the sequence similarity is relatively low with human PrP (approximately 60%), the major domains, including tandem repeat regions and glycosylation sites, are genetically conserved between the two species (18, 19). In addition, the mRNA expression pattern of the PRNP gene in the central nervous system is similar in both mammals and birds. Notably, chickens were found to be resistant to experimental BSE infection (20). In addition, chickens have no SNPs in the open reading frame (ORF) of the PRNP gene, which may affect the structural properties of PrP (21). In contrast, duck, which show an evolutionarily close relationship with chickens, has additional β-sheet structures in its PrP compared to chicken PrP. Furthermore, duck PrP showed a higher amyloid propensity than chicken PrP, and duck-specific amino acids conferred a high amyloid propensity to chicken PrP (22). Thus, it is necessary to investigate the genetic characteristics related to prion diseases in birds. In a previous genomic study, microsatellite markers of quail showed significant sequence identities with those of chickens despite 35 million years of their divergence (23). In addition, among the above 20 species of quails around the world, 14 million Japanese quails (Coturnix japonica) are bred for eggs and meat in Korea. Although quail is eaten directly, investigation of the genetic properties of the quail PRNP gene related to prion diseases has not been performed. Thus, the purpose of this study was to investigate the genetic characteristics of the quail PRNP gene in 164 Japanese quails.

Materials and Methods

Ethical Statements

A total of 164 Japanese quail samples were obtained from slaughterhouses in the Republic of Korea. All experimental protocols were approved by the Institutional of Animal Care and Use Committee (IACUC) of Jeonbuk National University (JBNU 2021-049). All efforts were made to minimize the number of animals used and their suffering.

Genomic DNA Extraction

Genomic DNA was extracted from 20 mg peripheral tissues of quails using BioFACT Multi-Bead™ genomic DNA prep kit (BioFACT, Daejeon, Korea) following the manufacturer's instructions.

Genetic Analysis of the Quail PRNP Gene

To amplify quail PRNP gene, gene-specific primers were designed and synthesized based on the quail PRNP gene registered in GenBank (GeneID: 107323677). The information on gene-specific primers of the quail PRNP gene was as follows, forward: 5'-AGGTCTATGCTCGCTGCTCT-3'; and reverse: 5'-AAGGACAAGGGACACCCCAT-3'. These primers were used to amplify the entire ORF of the quail PRNP gene. Polymerase chain reaction (PCR) was performed with 2.5 μl of 10 x Taq polymerase reaction buffer (25 mM), 5 μl of 5 x band helper, 0.5 μl of dNTPs (each 10 mM), 1 μl of each forward and reverse primers (each 10 μM), 0.12 μl of Taq polymerase (5 U/μl) (BioFACT, Daejeon, Korea), 3 μl of template genomic DNA (25-30 ng/μl), and 11.88 μl of nuclease-free water to a total volume of 25 μl. The PCR conditions were as follows: 1 cycle of predenaturation at 98°C for 2 min, 34 cycles of denaturation at 95°C for 20 s, annealing at 60°C for 40 s, elongation at 72°C for 1 min 30 s, and 1 cycle of final elongation at 72°C for 5 min. The experiments were performed using an S-1000 Thermal Cycler (Bio–Rad, Hercules, CA, USA). The PCR product stained with ethidium bromide (EtBr) was loaded to a gel electrophoresis system and then eluted by the Favor prep™ GEL/PCR purification kit (FAVORGEN, PingTung, Taiwan). The purified PCR products were sequenced using BigDye Terminator cycle sequencing kit (ABI, Foster City, CA, USA). The fluorescent PCR protocol consists of an initial 60 s incubation at 96°C, followed by 25 cycles of 96°C for 10 s, 50°C for 5 s, and 60°C for 75 s. Then, PCR products were loaded into an ABI 3730 Capillary Sequencer (ABI, Foster City, CA, USA). The sequencing results were read by the Finch TV program (Geospriza Inc., Seattle, WA, USA), and genotyping was carried out.

Statistical Analysis

Linkage disequilibrium (LD) and haplotype analyses were performed using Haploview program ver. 4.2 (Broad Institute, Cambridge, MA, USA).

In silico Evaluation of the Effect of Amino Acid Substitution

The effect of amino acid substitution was estimated by four in silico programs, including Protein Variation Effect Analyzer (PROVEAN), Protein Analysis Through Evolutionary Relationships (PAHTHER), Sorting Intolerant From Tolerant (SIFT) programs, and combined Amyloid and Composition-based prediction of the prion-like aggregation propensity (AMYCO) (24–27). PROVEAN (http://provean.jcvi.org/seq_submit.php) predicts the effect of amino acid substitution on the biological function of proteins and is scored by calculating clustering BLAST hits of homologs collected from the NCBI database. When the score is < -2.5, it is predicted as “deleterious,” and when it is above −2.5, it is predicted as “neutral.” PANTHER (http://www.pantherdb.org) estimates the likelihood of a non-synonymous SNP to cause a functional impact on the protein. It evaluates amino acid substitution by calculating the time conserved during the evolution of species. Scores based on retention time are as follows: “most likely damaging” if >450 my (~0.2), “possibly damaging” for scores between 200 my and 450 my (~0.4), and “most likely benign” for <200 my. SIFT (https://sift.bii.a-star.edu.sg/) predicts substitution effects based on sequence homology, and the prediction results are described as follows: normalized probabilities ≤ 0.05 are predicted to be damaging, whereas those with normalized probabilities >0.05 are predicted to be tolerated. AMYCO (http://bioinf.uab.es/amycov04/) predicts the effect of amino acid substitution aggregation propensity. It uses the pWALTZ and PAPA algorithms and calculates the results with the PSEP score. An AMYCO score below 0.45 indicates low amyloid propensity while an AMYCO score above 0.74 indicates high amyloid propensity.

Phylogenetic Analysis

To analyze the genetic relationship, phylogenetic analysis was performed in five species, including chicken, turkey, goose, duck, and quail using Molecular Evolutionary Genetic Analysis X (MEGA X) program (28). Detailed information on the species analyzed in this study is described in Table 1. The evolutionary tree was drawn using neighbor joining method with 2,000 bootstrap tests. The branch length of phylogenetic tree represents the evolutionary distance, which was calculated amino acid substitution by Poisson correction method.
Table 1

Detailed information on the avian sequences analyzed in this study.

Common name Scientific name GenBank ID
Chicken Gallus gallus NP_990796.2
Turkey Meleagris gallopavo XP_003212430.1
Goose Anser cygnoides XP_013054700.1
Duck Anas platyrhynchos domestica Jeong et al. [21]
Quail Coturnix japonica XP_015738493.1
Detailed information on the avian sequences analyzed in this study.

Multiple Sequence Alignment

To find quail-specific amino acids, multiple sequence alignment was performed in the above-mentioned five avian species using Clustal Omega (29) (https://www.ebi.ac.uk/Tools/msa/clustalo/).

SWISS-Model

The 3D structure of avian PrPs was analyzed by SWISS-MODEL program (30), with the highest global model quality estimation (GMQE) score selected to predict avian PrPs. The modeling quality was estimated by a qualitative model energy analysis (QMEAN) score. Hydrogen bond analysis was performed to calculate the change in the bond or distance of the hydrogen bond due to amino acid substitution. Hydrogen bonds were predicted if hydrogen was in the 1.2 to 2.76 Å range for a compatible donor atom.

AlphaFold

To validate the 3D structure of avian PrPs predicted by SWISS-Model, avian PrPs were analyzed by AlphaFold based on machine learning (https://colab.research.google.com/github/deepmind/alphafold/blob/main/notebooks/AlphaFold.ipynb). The intra-domain confidence of modeling was estimated by predicted local distance difference test (pLDDT) score on a scale from 0 to 100.

Results

Identification of Novel Genetic Polymorphisms of the Quail PRNP Gene

To amplify the quail PRNP gene, PCR was performed with gene-specific primers. The quail PRNP gene is located on chromosome 22 and consists of three exons. The ORF is located at exon 3. The size of our PCR products (801 bp) was identical to that of the quail PRNP gene registered in GenBank (GeneID: 107323677). To identify the genetic polymorphisms of the quail PRNP gene, we performed DNA sequencing in 164 quails. We found a total of 33 novel SNPs, including 28 SNPs at c.12C>T, c.15C>T, c.60C>T, c.111T>C, c.126C>T, c.144C>T, c.162T>C, c.168G>A, c.171G>A,C, c.174T>C, c.186A>G, c.192C>T, c.222C>T, c.321G>A, c.357G>A, c.453C>T, c.459G>A, c.463C>A, c.474C>T, c.486G>A, c.540T>C, c.546C>T, c.645C>T, c.678G>T, c.685C>T, c.702G>A, c.705T>C, and c.714C>T, along with three nonsynonymous SNPs at c.56C>T (T19I), c.61G>A (V21I), and c.64G>T (A22S) in the ORF region and two SNPs at c.806A>G and 811G>A in the 3' untranslated region (UTR) (Figure 1A). Electropherograms of the 33 novel SNPs are shown in Figure 1B. Notably, insertion/deletion polymorphisms were not found in the quail PRNP gene. Detailed information on the genotype and allele frequencies of the 33 SNPs of the quail PRNP gene is described in Table 2. In addition, we performed LD analysis to evaluate genetic linkage among 33 SNPs of the quail PRNP gene using the r2 value. Detailed LD values are described in Table 3. Furthermore, we performed haplotype analysis on the 33 SNPs of the quail PRNP gene. Briefly, seven major haplotypes were found. The haplotype present in the highest proportion was CCCCGGTCCTGGTACCGGCGCCGTCCGCGTCAG (62.5%), followed by CCCCAGCCCTAATGTCAACACCACCCTCATCAG (5.2%) and CCTTGTTCCCAACACCGATGCCGTCTGCGCCAA (2.1%) (Table 4).
Figure 1

Novel single nucleotide polymorphisms (SNPs) in the quail prion protein gene (PRNP) were found in this study. (A) Schematic map of the quail PRNP gene with SNPs. T19I, V21I, and A22S indicate three nonsynonymous SNPs. (B) Electropherograms of the 33 novel SNPs in the quail PRNP gene. The colors of the peaks indicate each base of the DNA sequence (green: adenine; red: thymine; blue: cytosine; and black: guanine). The red arrows indicate the location of the SNPs found in this study.

Table 2

Genotype and allele frequencies of the single nucleotide polymorphisms in the quail prion protein gene (PRNP).

Polymorphism Genotype frequency; n (%)Allele frequency; n (%)
M/M M/m m/m M m
c.12C>T152 (92.68)3 (1.83)9 (5.49)307 (93.60)21 (6.40)
c.15C>T160 (97.56)2 (1.22)2 (1.22)322 (98.17)6 (1.83)
c.56C>T (T19I)137 (83.54)15 (9.15)12 (7.31)289 (88.11)39 (11.89)
c.60C>T141 (85.97)15 (9.15)8 (4.88)297 (90.55)31 (9.45)
c.61G>A (V21I)138 (84.15)16 (9.76)10 (6.09)292 (89.02)36 (10.98)
c.64G>T (A22S)137 (83.54)17 (10.37)10 (6.09)291 (88.72)37 (11.28)
c.111T>C120 (73.17)27 (16.46)17 (10.37)267 (81.40)61 (18.60)
c.126C>T157 (95.73)2 (1.22)5 (3.05)316 (96.34)12 (3.66)
c.144C>T150 (91.46)7 (4.27)7 (4.27)307 (93.60)21 (6.40)
c.162T>C142 (86.58)15 (9.15)7 (4.27)299 (91.16)29 (8.84)
c.168G>A103 (62.81)30 (18.29)31 (18.90)236 (71.95)92 (28.05)
c.171G>A; C109 (66.46)28 (17.07)27 (16.47)298 (90.85)30 (9.15)
c.174T>C146 (89.02)9 (5.49)9 (5.49)301 (91.77)28 (8.23)
c.186A>G151 (92.07)3 (1.83)10 (6.10)305 (92.99)23 (7.01)
c.192C>T133 (81.10)21 (12.80)10 (6.10)287 (87.50)41 (12.5)
c.222C>T158 (96.34)5 (3.05)1 (0.61)321 (97.87)7 (2.13)
c.321G>A140 (85.37)14 (8.53)10 (6.10)294 (89.63)34 (10.37)
c.357G>A98 (59.76)33 (20.12)33 (20.12)229 (69.82)99 (30.18)
c.453C>T140 (85.37)17 (10.367 (4.27)297 (90.55)31 (9.45)
c.459G>A133 (81.10)21 (12.80)10 (6.10)287 (87.50)41 (12.50)
c.463C>A161 (98.17)2 (1.22)1 (0.61)324 (98.78)4 (1.22)
c.474C>T161 (98.17)2 (1.22)1 (0.61)324 (98.78)4 (1.22)
c.486G>A133 (81.10)21 (12.80)10 (6.10)287 (87.50)41 (12.50)
c.540T>C131 (79.88)23 (14.02)10 (6.10)285 (86.89)43 (13.11)
c.546C>T157 (95.73)6 (3.66)1 (0.61)320 (97.56)8 (2.44)
c.645C>T142 (86.58)16 (9.76)6 (3.66)300 (91.46)28 (8.54)
c.678G>T136 (82.93)18 (10.97)10 (6.10)290 (88.42)38 (11.58)
c.684C>T162 (98.78)1 (0.61)1 (0.61)325 (99.09)3 (0.91)
c.702G>A132 (80.49)19 (11.59)13 (7.92)283 (86.28)45 (13.72)
c.705T>C144 (87.81)13 (7.92)7 (4.27)301 (91.77)27 (8.23)
c.714C>T152 (92.68)12 (7.32)0 (0)316 (96.34)12 (3.66)
c.806A>G158 (96.93)2 (1.23)3 (1.84)318 (98.15)6 (1.85)
c.811G>A143 (87.73)17 (10.43)3 (1.84)303 (92.95)23 (7.05)

MM, major homozygote; Mm: heterozygote; mm, minor homozygote; M, major allele; and m: minor allele.

Table 3

Linkage disequilibrium (LD) score of the single nucleotide polymorphisms in the quail prion protein gene (PRNP).

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33
1 -
2 0.023-
3 0.0020.051-
4 0.0070.069 0.663 -
5 0.0080.0020.0090.013-
6 0.0090.055 0.776 0.705 0.016-
7 0.1470.010.0090.024 0.502 0.011-
8 0.00.210.1070.1060.0050.1510.001-
9 0.240.0230.0090.0070.00.0090.20.003-
10 0.0070.0 0.609 0.495 0.012 0.647 0.0220.00.007-
11 0.1530.090.2050.1340.290.208 0.558 0.0010.1080.249-
12 0.1550.0130.2470.1640.1730.249 0.386 0.0010.1070.291 0.826 -
13 0.1380.0160.1260.1170.0080.0890.0720.030.1770.0160.1830.216-
14 0.0050.0010.010.008 0.612 0.010.330.0030.0050.0070.1930.1530.007-
15 0.00.0030.0190.015 0.705 0.005 0.514 0.00.0010.014 0.315 0.2450.0 0.528 -
16 0.001 0.37 0.1110.0950.0030.1180.005 0.416 0.0010.00.0060.0010.0010.0020.003-
17 0.0080.0020.0080.012 0.877 0.007 0.469 0.0040.00.0110.2970.1740.006 0.652 0.653 0.003-
18 0.1370.0430.2640.1740.2610.27 0.503 0.0350.1140.201 0.846 0.717 0.1440.174 0.306 0.0280.244-
19 0.0050.0 0.611 0.506 0.013 0.649 0.0240.0020.007 0.859 0.268 0.313 0.1170.0080.0060.0030.0120.241-
20 0.010.0030.0080.015 0.863 0.0070.550.0050.0010.01 0.315 0.1830.006 0.528 0.788 0.003 0.81 0.306 0.014-
21 0.180.00.0020.0010.0020.0120.0540.0120.0010.0010.0320.0370.0010.0010.00.00.0010.0290.0010.002-
22 0.180.00.0020.0010.0020.0120.0540.0120.0010.0010.0320.0370.0010.0010.00.00.0010.0290.0010.002 1.0 -
23 0.010.0030.0080.015 0.863 0.0070.550.0050.0010.01 0.315 0.1830.006 0.528 0.788 0.003 0.81 0.306 0.014 1.0 0.0020.002-
24 0.0050.0030.010.016 0.715 0.004 0.585 0.0060.0010.005 0.361 0.2240.009 0.451 0.697 0.003 0.715 0.324 0.008 0.843 0.0820.082 0.843 -
25 0.040.00.0030.0030.0030.0030.0110.0020.00.0020.0040.0060.0020.00.00.0010.0020.0080.0030.0040.2720.2720.0040.025-
26 0.0070.0 0.582 0.463 0.012 0.619 0.0210.0030.006 0.888 0.2390.280.1380.070.0080.0050.0110.216 0.894 0.0080.0010.0010.0080.0040.002-
27 0.0090.0020.0080.014 0.826 0.017 0.536 0.0050.00.013 0.31 0.1730.011 0.52 0.708 0.003 0.768 0.2790.009 0.863 0.0020.002 0.863 0.716 0.0030.012-
28 0.1350.00.0010.0010.0010.0010.040.0190.0010.0010.0240.0280.0010.0010.0010.00.0010.0210.0010.001 0.748 0.748 0.0010.061 0.639 0.0010.001-
29 0.0030.0030.0060.006 0.775 0.002 0.514 0.0060.0010.002 0.308 0.1890.001 0.474 0.751 0.003 0.727 0.2960.004 0.898 0.00.0 0.898 0.80.00.002 0.774 0.0-
30 0.0030.0 0.556 0.485 0.011 0.647 0.0020.00.006 0.851 0.230.2690.0890.0070.0130.00.010.207 0.859 0.0060.0010.0010.0060.0020.002 0.811 0.0110.0010.001-
31 0.00.0050.00.0020.0250.00.0650.0020.0020.0030.0290.0130.0030.00.0350.0030.0040.0240.0020.0580.00.00.0580.0530.0010.0040.0410.00.0520.005-
32 0.002 0.321 0.0320.0450.0030.0350.00.1520.040.0010.00.00.0010.0020.040.2710.0030.0110.0020.0040.00.00.0040.0040.0010.0010.0030.00.0040.0010.003-
33 0.0030.0 0.451 0.359 0.009 0.479 0.0130.00.005 0.704 0.1960.2260.1120.0060.0110.00.0090.177 0.722 0.0060.0030.0030.0060.0020.002 0.732 0.010.0010.001 0.687 0.0010.0-

1, c.12C>T; 2, c.15C>T; 3, c.56C>T (T19I); 4, c.60C>T; 5, c.61G>A (V21I); 6, c.64G>T (A22S); 7, c.111T>C; 8, c.126C>T; 9, c.144C>T; 10, c.162T>C; 11, c.168G>A; 12, c.171G>A; 13, c.174T>C; 14, c.186A>G; 15, c.192C>T; 16, c.222C>T; 17, c.321G>A; 18, c.357G>A; 19, c.453C>T; 20, c.459G>A; 21, c.463C>A; 22, c.474C>T; 23, c.486G>A; 24, c.540T>C; 25: c.546C>T; 26, c.645C>T; 27, c.678G>T; 28: c.684C>T; 29, c.702G>A; 30, c.705T>C; 31, c714C>T; 32, c.806A>G; and 33, c.811G>A. Bold font means strong LD (r.

Table 4

Haplotype frequencies of the quail prion protein gene (PRNP).

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 Frequency (n = 328)
HT1CCCCGGTCCTGGTACCGGCGCCGTCCGCGTCAG205 (0.625)
HT2CCCCAGCCCTAATGTCAACACCACCCTCATCAG17 (0.052)
HT3CCTTGTTCCCAACACCGATGCCGTCTGCGCCAA7 (0.021)
HT4CCTTGTTCCCAATACCGATGCCGTCTGCGCCAA6 (0.019)
HT5TCCCGGCCTTAACACCGACGCCGTCCGCGTCAG6 (0.018)
HT6CCCCGGTCCTGGTACCGGCGCCGTTCGCGTCAG5 (0.015)
HT7CTTTGTTTCTGGTACTGACGCCGTCCGCGTCGG4 (0.012)
Others---------------------------------78 (0.238)

1, c.12C>T; 2, c.15C>T; 3, c.56C>T (T19I); 4, c.60C>T; 5, c.61G>A (V21I); 6, c.64G>T (A22S); 7, c.111T>C; 8, c.126C>T; 9, c.144C>T; 10, c.162T>C; 11, c.168G>A; 12, c.171G>A; 13, c.174T>C; 14, c.186A>C; 15, c.192C>T; 16, c.222C>T; 17, c.321G>A; 18, c.357G>A; 19, c.453C>T; 20, c.459G>A; 21, c.463C>T; 22, c.474C>T; 23, c.486G>A; 24, c.540T>C; 25, c.546C>T; 26, c.645C>T; 27, c.678G>T; 28, c.684C>T; 29, c.702G>A; 30, c.705T>C; 31, c714C>T; 32, c.806A>G; and 33, c.811G>A.

Novel single nucleotide polymorphisms (SNPs) in the quail prion protein gene (PRNP) were found in this study. (A) Schematic map of the quail PRNP gene with SNPs. T19I, V21I, and A22S indicate three nonsynonymous SNPs. (B) Electropherograms of the 33 novel SNPs in the quail PRNP gene. The colors of the peaks indicate each base of the DNA sequence (green: adenine; red: thymine; blue: cytosine; and black: guanine). The red arrows indicate the location of the SNPs found in this study. Genotype and allele frequencies of the single nucleotide polymorphisms in the quail prion protein gene (PRNP). MM, major homozygote; Mm: heterozygote; mm, minor homozygote; M, major allele; and m: minor allele. Linkage disequilibrium (LD) score of the single nucleotide polymorphisms in the quail prion protein gene (PRNP). 1, c.12C>T; 2, c.15C>T; 3, c.56C>T (T19I); 4, c.60C>T; 5, c.61G>A (V21I); 6, c.64G>T (A22S); 7, c.111T>C; 8, c.126C>T; 9, c.144C>T; 10, c.162T>C; 11, c.168G>A; 12, c.171G>A; 13, c.174T>C; 14, c.186A>G; 15, c.192C>T; 16, c.222C>T; 17, c.321G>A; 18, c.357G>A; 19, c.453C>T; 20, c.459G>A; 21, c.463C>A; 22, c.474C>T; 23, c.486G>A; 24, c.540T>C; 25: c.546C>T; 26, c.645C>T; 27, c.678G>T; 28: c.684C>T; 29, c.702G>A; 30, c.705T>C; 31, c714C>T; 32, c.806A>G; and 33, c.811G>A. Bold font means strong LD (r. Haplotype frequencies of the quail prion protein gene (PRNP). 1, c.12C>T; 2, c.15C>T; 3, c.56C>T (T19I); 4, c.60C>T; 5, c.61G>A (V21I); 6, c.64G>T (A22S); 7, c.111T>C; 8, c.126C>T; 9, c.144C>T; 10, c.162T>C; 11, c.168G>A; 12, c.171G>A; 13, c.174T>C; 14, c.186A>C; 15, c.192C>T; 16, c.222C>T; 17, c.321G>A; 18, c.357G>A; 19, c.453C>T; 20, c.459G>A; 21, c.463C>T; 22, c.474C>T; 23, c.486G>A; 24, c.540T>C; 25, c.546C>T; 26, c.645C>T; 27, c.678G>T; 28, c.684C>T; 29, c.702G>A; 30, c.705T>C; 31, c714C>T; 32, c.806A>G; and 33, c.811G>A.

In silico Evaluation of the Effect of Non-synonymous SNPs on Quail PrP

To analyze the functional and structural effects of nonsynonymous SNPs on quail PrP, PROVEAN, PANTEHR, and SIFT programs were used. T19I and A22S were predicted to have benign effects on quail PrP by all three programs. In addition, V21I was predicted by PROVEAN and PANTHER to have a neutral effect on quail PrP. However, V21I was predicted to have a deleterious effect on quail PrP by SIFT (Table 5). To analyze the effect of nonsynonymous SNPs on the amyloid propensity of quail PrP, the AMYCO program was used. Notably, T19I, V21I, and A22S were predicted to have low amyloid propensity with a score of “0” (Table 5). T19, I19, V21, and I21 alleles were predicted to have no hydrogen bond. A22 and S22 alleles were predicted to have one hydrogen bond with S24 (1.99 Å) (Figure 2).
Table 5

In silico evaluation on effect of nonsynonymous single nucleotide polymorphisms in the quail prion protein gene (PRNP).

Polymorphism Method Score Prediction
c.56C>T(T19I)PROVEAN PANTHER SIFT AMYCO−1.266 0.02 0.285 0.0Neutral Probably benign Tolerated Neutral
c.61G>A(V21I)PROVEAN PANTHER SIFT AMYCO−0.453 0.02 0.020 0.0Neutral Probably benign Damaging Neutral
c.64G>T(A22S)PROVEAN PANTHER SIFT AMYCO0.473 0.02 0.480 0.0Neutral Probably benign Tolerated Neutral
Figure 2

Prediction of tertiary structure and hydrogen bonds of quail prion protein (PrP). (A) Comparison of the 3D structure and hydrogen bond of quail PrP according to the T19I alleles. The left panel indicates the 3D structure of quail PrP with allele T19. The right panel indicates the 3D structure of quail PrP with allele I19. (B) Comparison of the 3D structure and hydrogen bond of quail PrP according to the V21I alleles. The left panel indicates the 3D structure of quail PrP with allele V21. The right panel indicates the 3D structure of quail PrP with allele I21. (C) Comparison of the 3D structure and hydrogen bond of quail PrP according to the A22S alleles. The left panel indicates the 3D structure of quail PrP with allele A22. The right panel indicates the 3D structure of quail PrP with allele S22. The green dotted lines indicate hydrogen bonds. The green numbers indicate the distance of the hydrogen bonds.

In silico evaluation on effect of nonsynonymous single nucleotide polymorphisms in the quail prion protein gene (PRNP). Prediction of tertiary structure and hydrogen bonds of quail prion protein (PrP). (A) Comparison of the 3D structure and hydrogen bond of quail PrP according to the T19I alleles. The left panel indicates the 3D structure of quail PrP with allele T19. The right panel indicates the 3D structure of quail PrP with allele I19. (B) Comparison of the 3D structure and hydrogen bond of quail PrP according to the V21I alleles. The left panel indicates the 3D structure of quail PrP with allele V21. The right panel indicates the 3D structure of quail PrP with allele I21. (C) Comparison of the 3D structure and hydrogen bond of quail PrP according to the A22S alleles. The left panel indicates the 3D structure of quail PrP with allele A22. The right panel indicates the 3D structure of quail PrP with allele S22. The green dotted lines indicate hydrogen bonds. The green numbers indicate the distance of the hydrogen bonds.

Analysis of Evolutionary Relationships and Multiple Sequence Alignment of Avian PrPs

To analyze the evolutionary relationship of quail PrP among avian species, phylogenetic analysis was performed in five avian species of chicken, turkey, goose, duck, and quail using MEGA X program. Notably, quail PrP showed the closest genetic distance to turkey PrP, followed by chicken PrP (Figure 3A). Multiple sequence alignment showed that length of the amino acid sequences of duck PrP was the longest (136 aa), while the length of the amino acid sequence of quail PrP (115 aa) was identical to those of turkey and goose. In addition, we found three quail-specific amino acids, namely S144, D214, and T259 (Figure 3B).
Figure 3

Comparison of the amino acid sequences among five avian PrPs. (A) Phylogenetic analysis of the PrPs in the five avian species. (B) Multiple sequence alignment of the amino acid sequences of the five avian PrPs. Colors indicate the chemical properties of amino acids, namely, blue: acidic; red: small and hydrophobic magenta: basic; and green: hydroxyl, sulfhydryl, amine, and glycine. Asterisks indicate quail-specific amino acids. Sharps indicate T19I, V21I, and A22S. (C) Comparison of tandem repeat sequences in the five avian species. R1 - R8 indicate hexapeptide repeat regions of avian PrPs.

Comparison of the amino acid sequences among five avian PrPs. (A) Phylogenetic analysis of the PrPs in the five avian species. (B) Multiple sequence alignment of the amino acid sequences of the five avian PrPs. Colors indicate the chemical properties of amino acids, namely, blue: acidic; red: small and hydrophobic magenta: basic; and green: hydroxyl, sulfhydryl, amine, and glycine. Asterisks indicate quail-specific amino acids. Sharps indicate T19I, V21I, and A22S. (C) Comparison of tandem repeat sequences in the five avian species. R1 - R8 indicate hexapeptide repeat regions of avian PrPs.

Comparison of Tandem Repeats of Avian PrPs

To identify the difference in tandem repeats in amino acid sequences among the five avian species, we aligned their tandem repeat regional sequences (Figure 3C). The result showed that both chicken and turkey PrPs had eight tandem repeats, followed by seven in quail and four each in geese and duck.

Comparison of the Secondary and Tertiary Structures of the Avian PrPs

SWISS-MODEL was used to analyze the secondary structure of avain PrPs (Figure 4, Table 6). In chicken, turkey, and goose PrPs, three α-helix and two β-sheet structures were observed, followed by five α-helix and four β-sheet structures in duck, and three α-helix and two β-sheet structures in quail. The proportion of the β-sheet structure of quail PrP was lower than that of duck (quail: 5.21%; duck: 8.82%). As shown in the secondary structure of avian PrPs, all avian PrPs showed similar tertiary structures (Figure 4B, Table 6). Since SWISS-MODEL has been predicted with a relatively low confidence (Table 6), we validated the 3D structure of avian PrPs using AlphaFold (Supplementary Figure 1). Notably, quail PrP showed a similar 3D structure with chicken PrP.
Figure 4

The secondary and tertiary structures of avian PrPs. (A) The secondary structure of the avian PrPs. (B) The tertiary structure of the avian PrPs. The colors indicate α-helices (red), β-sheets (yellow), and coils (white).

Table 6

Detailed information on the secondary and tertiary structures of avian prion proteins (PrPs).

Species Template QMEAN GMQE Range Information of α-helicesInformation of β-sheets
Location Overall ratio Location Overall ratio
Chicken1u3m--117 (126–242)151–161, 179–194, 213–24047.00136–138, 168–1705.12
Turkey1u3m.1−3.850.31115 (133–247)156–166, 184–199, 218-24547.82141–143, 173–1755.21
Goose1u3m.1.A−4.100.38115 (117–231)140–150, 168–183, 202–22947.82125–127, 157–1595.21
Duck2lft.1.A−3.80.37136 (95–230)140–147, 151, 168, 172–182, 206–22832.67125–127, 157–159, 195–197, 200–2028.82
Quail1u3m.1.A−3.890.34115 (128–242)151–161, 179–194, 213–24047.82136–138, 168–1705.21
The secondary and tertiary structures of avian PrPs. (A) The secondary structure of the avian PrPs. (B) The tertiary structure of the avian PrPs. The colors indicate α-helices (red), β-sheets (yellow), and coils (white). Detailed information on the secondary and tertiary structures of avian prion proteins (PrPs). QMEAN, qualitative model energy analysis; GMQE, global model quality estimation.

Amyloid Propensity of Amino Acid Substitutions

To analyze the amyloid propensity of the substitutions of three amino acids on avian PrPs, we evaluated amyloid propensity according to the allele using AMYCO (Table 7). Among the five avian species, duck PrP was predicted to have the highest amyloid propensity (44) compared to all other four avian PrPs. Notably, the amyloid propensity of the avian PrPs was not changed by any substitution of the three amino acids.
Table 7

AMYCO analysis according to alleles of avian PrPs.

Chicken Turkey Goose Duck Quail
Wild type0.000.000.000.000.44
T19I0.000.000.000.000.44
V21I0.000.000.000.000.44
A22S0.000.000.000.000.44
AMYCO analysis according to alleles of avian PrPs.

Discussion

Prion protein is a GPI-anchor protein. Notably, a V21I is located on the signal peptide of PrP, which plays a pivotal role in the trafficking of PrP (31, 32). Previous studies have reported that a block of trafficking of PrP via mutagenesis of PrP's signal peptide affects the resistance to the conversion of PrPC to PrPSc (33, 34). Since we predicted the deleterious effect of V21I on quail PrP (Table 5), further in vitro validation of its impact on the cellular localization of quail PrP using a reporter system is highly desirable in the future. In previous studies, insertion/deletion polymorphisms of the PRNP gene have been related to susceptibility to several types of prion diseases (35, 36). In humans, insertion polymorphisms of octapeptide repeats of the PRNP gene are more frequently observed in patients with human genetic prion disease. Furthermore, 23- and 12-bp insertion/deletion polymorphisms regulate the expression level of the bovine PRNP gene and are associated with susceptibility to classical BSE. Furthermore, we found strong LD among six SNPs (Table 3), indicating a clear LD block in the ORF of the PRNP gene.

Conclusion

In this study, we found 33 novel SNPs in the quail PRNP gene. We predicted V21I to have a deleterious effect on quail PrP. In addition, quail PrP showed a close evolutionary relationship and similar secondary and tertiary structures to chicken PrP. To our knowledge, this was the first report on the genetic and structural properties of the quail PRNP gene.

Data Availability Statement

The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/Supplementary Material.

Ethics Statement

The animal study was reviewed and approved by Institutional Animal Care and Use Committee of Jeonbuk National University.

Author Contributions

YK, Y-CK, and B-HJ conceived and designed the experiment, analyzed the data, and wrote the paper. YK and Y-CK performed the experiments. All authors read and approved the final manuscript.

Funding

YK supported by the BK21 Plus Program in the Department of Bioactive Material Sciences. This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (2017R1A6A1A03015876 and 2021R1A6A3A010864), the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (2021R1A2C1013213), and a National Research Foundation of Korea (NRF) grant funded by the Korean Government (NRF-2019-Fostering Core Leaders of the Future Basic Science Program/Global Ph.D. Fellowship Program).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
  35 in total

1.  The GPI-anchoring of PrP: implications in sorting and pathogenesis.

Authors:  Berta Puig; Hermann Altmeppen; Markus Glatzel
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

Review 2.  Genetic Factors in Mammalian Prion Diseases.

Authors:  Simon Mead; Sarah Lloyd; John Collinge
Journal:  Annu Rev Genet       Date:  2019-09-19       Impact factor: 16.830

Review 3.  Creutzfeldt-Jakob disease.

Authors:  Beata Sikorska; Richard Knight; James W Ironside; Paweł P Liberski
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  The highways and byways of prion protein trafficking.

Authors:  Vincenza Campana; Daniela Sarnataro; Chiara Zurzolo
Journal:  Trends Cell Biol       Date:  2005-02       Impact factor: 20.808

5.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information.

Authors:  Marco Biasini; Stefan Bienert; Andrew Waterhouse; Konstantin Arnold; Gabriel Studer; Tobias Schmidt; Florian Kiefer; Tiziano Gallo Cassarino; Martino Bertoni; Lorenza Bordoli; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2014-04-29       Impact factor: 16.971

Review 6.  Genetic studies in human prion diseases.

Authors:  Byung-Hoon Jeong; Yong-Sun Kim
Journal:  J Korean Med Sci       Date:  2014-04-25       Impact factor: 2.153

7.  The First Report of the Prion Protein Gene (PRNP) Sequence in Pekin Ducks (Anas platyrhynchos domestica): The Potential Prion Disease Susceptibility in Ducks.

Authors:  Min-Ju Jeong; Yong-Chan Kim; Byung-Hoon Jeong
Journal:  Genes (Basel)       Date:  2021-01-28       Impact factor: 4.096

Review 8.  Prion protein misfolding.

Authors:  L Kupfer; W Hinrichs; M H Groschup
Journal:  Curr Mol Med       Date:  2009-09       Impact factor: 2.222

9.  AMYCO: evaluation of mutational impact on prion-like proteins aggregation propensity.

Authors:  Valentin Iglesias; Oscar Conchillo-Sole; Cristina Batlle; Salvador Ventura
Journal:  BMC Bioinformatics       Date:  2019-01-14       Impact factor: 3.169

View more
  1 in total

1.  First report of structural characteristics and polymorphisms of the prion protein gene in raccoon dogs: The possibility of prion disease-resistance.

Authors:  Woo-Sung Jo; Yong-Chan Kim; Jae-Ku Oem; Byung-Hoon Jeong
Journal:  Front Vet Sci       Date:  2022-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.